Cost-Benefit of Stockpiling Drugs for Influenza Pandemic
We analyzed strategies for the use of stockpiled antiviral drugs in the context of a future influenza pandemic and estimated cost-benefit ratios. Current stockpiling of oseltamivir appears to be cost-saving to the economy under several treatment strategies, including therapeutic treatment of patient...
| Autores principales: | , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | English |
| Publicado: |
Centers for Disease Control and Prevention
2005-08-01
|
| Colección: | Emerging Infectious Diseases |
| Materias: | |
| Acceso en línea: | https://wwwnc.cdc.gov/eid/article/11/8/04-1156_article |